FR2415301B1 - - Google Patents

Info

Publication number
FR2415301B1
FR2415301B1 FR7900498A FR7900498A FR2415301B1 FR 2415301 B1 FR2415301 B1 FR 2415301B1 FR 7900498 A FR7900498 A FR 7900498A FR 7900498 A FR7900498 A FR 7900498A FR 2415301 B1 FR2415301 B1 FR 2415301B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7900498A
Other languages
French (fr)
Other versions
FR2415301A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Travenol Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Laboratories Inc filed Critical Baxter Travenol Laboratories Inc
Publication of FR2415301A1 publication Critical patent/FR2415301A1/fr
Application granted granted Critical
Publication of FR2415301B1 publication Critical patent/FR2415301B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR7900498A 1978-01-23 1979-01-10 Procede et composition pour determination par fixation specifique avec un recepteur double d'un ligand echantillon Granted FR2415301A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87147878A 1978-01-23 1978-01-23
US05/930,130 US4271140A (en) 1978-01-23 1978-08-01 Method and composition for double receptor, specific binding assays

Publications (2)

Publication Number Publication Date
FR2415301A1 FR2415301A1 (fr) 1979-08-17
FR2415301B1 true FR2415301B1 (US20030220297A1-20031127-C00074.png) 1984-05-11

Family

ID=27128209

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7900498A Granted FR2415301A1 (fr) 1978-01-23 1979-01-10 Procede et composition pour determination par fixation specifique avec un recepteur double d'un ligand echantillon

Country Status (5)

Country Link
US (1) US4271140A (US20030220297A1-20031127-C00074.png)
JP (1) JPS54104391A (US20030220297A1-20031127-C00074.png)
DE (1) DE2902400A1 (US20030220297A1-20031127-C00074.png)
FR (1) FR2415301A1 (US20030220297A1-20031127-C00074.png)
GB (1) GB2012954B (US20030220297A1-20031127-C00074.png)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495296A (en) * 1979-05-21 1985-01-22 New York Blood Center, Inc. Labeled anti-hapten antibodies and their use as a universal reagent for solid phase radio- and/or enzyme-immunoassays
US4451571A (en) * 1981-04-06 1984-05-29 University Patents, Inc. Preparation of samples for vitamin B12 and/or folate assay and assay
US4481298A (en) * 1981-04-13 1984-11-06 Amf Incorporated Pre-precipitated double antibody immunoassay method
NL8102178A (nl) * 1981-05-02 1982-12-01 Stichting Centraal Lab Werkwijze voor het aantonen van tegen bepaalde antigenen gerichte antistoffen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze.
US4994373A (en) 1983-01-27 1991-02-19 Enzo Biochem, Inc. Method and structures employing chemically-labelled polynucleotide probes
FR2542871B1 (fr) * 1983-03-15 1986-05-16 Pasteur Institut Procede de dosage en phase heterogene de substances biologiques antigeniques, mettant en oeuvre des conjugues hybrides d'anticorps et reactifs pour sa mise en oeuvre
US4737453A (en) * 1984-12-12 1988-04-12 Immunomedics, Inc. Sandwich immunoassay utilizing a separation specific binding substance
US4935339A (en) * 1985-05-07 1990-06-19 Nichols Institute Diagnostics Delayed solid phase immunologic assay
GB8728856D0 (en) * 1987-12-10 1988-01-27 Bradwell A R Tumour-locating agents & method of locating tumours
CA2095642C (en) * 1990-08-02 1999-12-14 Howard C. Krivan Adhesion receptors for pathogenic or opportunistic microorganisms
IE920778A1 (en) * 1991-03-12 1992-09-23 Du Pont Method for specific binding assays using a releasable ligand
ATE184703T1 (de) * 1991-07-19 1999-10-15 Cytimmune Sciences Inc Verfahren und testsatz zur messung von endogenen zytokinen
US5965379A (en) * 1991-07-19 1999-10-12 Cytimmune Sciences Inc. Method for measuring endogenous cytokines
JP2665850B2 (ja) * 1991-11-14 1997-10-22 塩野義製薬株式会社 ｈＢＮＰのＣ端を認識するモノクロ−ナル抗体
AU654761B2 (en) * 1992-01-06 1994-11-17 Dade International Inc. Binding protein capture assay
US5518887A (en) * 1992-03-30 1996-05-21 Abbott Laboratories Immunoassays empolying generic anti-hapten antibodies and materials for use therein
US6610493B1 (en) * 1993-06-17 2003-08-26 Brigham And Women's Hospital Screening compounds for the ability to alter the production of amyloid-β peptide
US6201109B1 (en) 1993-01-13 2001-03-13 Dade Behring Marburg Gmbh Assay for bone alkaline phosphatase
US5434087A (en) * 1993-02-24 1995-07-18 Abbott Laboratories Folate immunoassay utilizing folate binding protein in a multiclonal antibody format
US5536820A (en) * 1993-02-26 1996-07-16 E. I. Du Pont De Nemours And Company Avidin-binding azo reagents
EP0728215B1 (en) * 1993-10-20 2002-02-20 Duke University METHOD OF BINDING MATERIAL TO THE Beta-AMYLOID PEPTIDE
DE4420742A1 (de) * 1993-10-20 1995-04-27 Boehringer Mannheim Gmbh Synthetischer Standard für Immunoassays
WO1995021942A1 (en) * 1994-02-15 1995-08-17 T Cell Diagnostics, Inc. Immunoassay kit comprising universal reagents
JPH08178926A (ja) * 1994-10-25 1996-07-12 Sumitomo Pharmaceut Co Ltd イムノアッセイプレートおよびその用途
US7427392B1 (en) 1994-11-14 2008-09-23 Elan Pharmaceuticals, Inc. Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
US5712103A (en) * 1995-02-13 1998-01-27 Regents Of The University Of California Diagnostic assay for the prediction of preeclampsia
US20040157262A1 (en) * 1996-04-30 2004-08-12 Michel Kohl Conjugates of haptens to beta-lactam derivatives and their use for detecting and/or quantifying haptens in solution and device for implementation thereof
SE9604575D0 (sv) 1996-12-12 1996-12-12 Biacore Ab Method and system for analyte determination
US6924153B1 (en) * 1997-03-06 2005-08-02 Quidel Corporation Quantitative lateral flow assays and devices
US6824986B1 (en) * 1997-10-06 2004-11-30 University Of Cincinnati Methods for measuring in vivo cytokine production
US6248546B1 (en) * 1998-03-09 2001-06-19 Diagnostic Systems Laboratories, Inc. Assay of IGFBP complex
AU768018C (en) * 1998-03-20 2004-09-30 Curators Of The University Of Missouri, The Early pregnancy diagnosis using PAGS (pregnancy- associated glycoproteins)
US6303325B1 (en) 1998-05-29 2001-10-16 Dade Behring Inc. Method for detecting analytes
US6289286B1 (en) * 1998-05-29 2001-09-11 Biacore Ab Surface regeneration of biosensors and characterization of biomolecules associated therewith
CA2270797A1 (en) * 1998-07-27 2000-01-27 Bayer Corporation Transparent flow through membrane for dry reagent analytical devices
JP4219491B2 (ja) * 1999-06-18 2009-02-04 富士フイルム株式会社 乾式分析方法及び乾式分析要素
TWI237695B (en) * 1999-12-14 2005-08-11 Joy Biomedical Corp Helicobacter pylori antigens in blood
US20020102717A1 (en) * 2000-12-09 2002-08-01 Hadeed Erika Lynn Refillable, reusable pregnancy test
US7105311B2 (en) * 2001-05-03 2006-09-12 Immunetics, Inc. Systems and methods for detection of analytes in biological fluids
WO2003043524A2 (en) * 2001-11-20 2003-05-30 The Curators Of The University Of Missouri Compositions and methods for accurate early pregnancy diagnosis
US20030175828A1 (en) * 2002-03-15 2003-09-18 Lazar James G. Signal amplification by Hybrid Capture
US20050214882A1 (en) * 2004-03-25 2005-09-29 Ez Bio Inc. Reagents, methods and kits for the universal rapid immuno-detection
US20090035216A1 (en) * 2007-08-03 2009-02-05 Biomonitor Aps Method for determining in vivo biopharmaceutical concentration or bioavailability
NZ586100A (en) * 2007-12-13 2012-07-27 Monsanto Technology Llc Compositions and methods for early pregnancy diagnosis using antibodies for pregancy-associated glycoproteins (PAGs)
WO2009126889A1 (en) * 2008-04-10 2009-10-15 The Curators Of The University Of Missouri Assays for detecting pregnancy- associated glycoproteins
DE102010064392A1 (de) * 2010-10-29 2012-05-03 Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG Verfahren zur Bestimmung eines Analytgehalts einer Flüssigkeitsprobe mittels eines Bioanalysators
CN102998469A (zh) * 2012-11-20 2013-03-27 博奥赛斯（天津）生物科技有限公司 叶酸磁微粒化学发光免疫定量检测试剂盒及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3646346A (en) * 1968-12-26 1972-02-29 Pharmacia Ab Antibody-coated tube system for radioimmunoassay
US3896217A (en) * 1973-03-19 1975-07-22 Summa Corp Method and apparatus for radioimmunoassay with regeneration of immunoadsorbent
US3935074A (en) * 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US4000252A (en) * 1974-01-04 1976-12-28 Kenneth Kosak Immunoscintillation cell
US4011308A (en) * 1974-01-04 1977-03-08 General Electric Company Method for surface immunological detection of biological particles by the use of tagged antibodies
US4041146A (en) * 1975-05-01 1977-08-09 General Electric Company Method for detection of biological particles
US4092408A (en) * 1975-08-28 1978-05-30 New England Nuclear Corporation Method for solid phase immunological assay of antigen
US4020151A (en) * 1976-02-17 1977-04-26 International Diagnostic Technology, Inc. Method for quantitation of antigens or antibodies on a solid surface
US4053284A (en) * 1976-03-10 1977-10-11 Akzona Incorporated Continuous flow apparatus for biological testing
US4120945A (en) * 1976-07-06 1978-10-17 Becton, Dickinson & Company Substrate coated with receptor and labeled ligand for assays
JPS604422B2 (ja) * 1976-10-07 1985-02-04 持田製薬株式会社 抗原の定量方法
US4108976A (en) * 1977-03-04 1978-08-22 Becton, Dickinson And Company Automated direct serum radioimmunoassay
JPS53148521A (en) * 1977-05-27 1978-12-25 Sanyo Chem Ind Ltd Hapten-antibody complex and its preparation

Also Published As

Publication number Publication date
DE2902400A1 (de) 1979-07-26
GB2012954A (en) 1979-08-01
GB2012954B (en) 1983-01-12
FR2415301A1 (fr) 1979-08-17
US4271140A (en) 1981-06-02
JPS6262289B2 (US20030220297A1-20031127-C00074.png) 1987-12-25
JPS54104391A (en) 1979-08-16

Similar Documents

Publication Publication Date Title
FR2415301B1 (US20030220297A1-20031127-C00074.png)
FR2415673B1 (US20030220297A1-20031127-C00074.png)
FR2415555B1 (US20030220297A1-20031127-C00074.png)
FR2415580B3 (US20030220297A1-20031127-C00074.png)
FR2415296B1 (US20030220297A1-20031127-C00074.png)
FR2416405B1 (US20030220297A1-20031127-C00074.png)
FR2416794B1 (US20030220297A1-20031127-C00074.png)
FR2417167B1 (US20030220297A1-20031127-C00074.png)
FR2414369B3 (US20030220297A1-20031127-C00074.png)
FR2415908B1 (US20030220297A1-20031127-C00074.png)
BG26009A1 (US20030220297A1-20031127-C00074.png)
BG26013A1 (US20030220297A1-20031127-C00074.png)
BG25871A1 (US20030220297A1-20031127-C00074.png)
BG26008A1 (US20030220297A1-20031127-C00074.png)
BG26007A1 (US20030220297A1-20031127-C00074.png)
BG26006A1 (US20030220297A1-20031127-C00074.png)
BG25974A1 (US20030220297A1-20031127-C00074.png)
BG25973A1 (US20030220297A1-20031127-C00074.png)
BG25972A1 (US20030220297A1-20031127-C00074.png)
BG25971A1 (US20030220297A1-20031127-C00074.png)
BG25957A1 (US20030220297A1-20031127-C00074.png)
BG25956A1 (US20030220297A1-20031127-C00074.png)
BG25955A1 (US20030220297A1-20031127-C00074.png)
BG25954A1 (US20030220297A1-20031127-C00074.png)
BG25952A1 (US20030220297A1-20031127-C00074.png)

Legal Events

Date Code Title Description
CD Change of name or company name
TP Transmission of property